Editor's Note
The Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee on September 17 voted that there was not enough safety and effectiveness data to approve a third Pfizer COVID-19 vaccine dose for those 16 years and older.
The committee did vote to recommend approval of a booster dose for people 65 years and older and those at high risk of severe COVID-19.
The committee also recommended approval of a booster for those with occupational risks, such as healthcare workers and teachers.
Read More >>The kind of Navy-taught leadership Brian Dawson, MSN, RN-BC, CNOR,…
Remote surgery has come a long way since the first-ever…
Every day, I come across postings in the media suggesting…